Synlico Inc.

Synlico Inc. is dedicated to transforming biology by leveraging causality to make cellular processes explainable, predictable, and engineerable. Focused on developing innovative therapies for oncology and other diseases, Synlico employs the latest advancements in artificial intelligence, causal discovery & inference, and single-cell bioinformatics.

Located at 329 Oyster Point Boulevard, 3rd Fl, South San Francisco, California 94080, US, Synlico Inc. stands at the forefront of biotechnology research. The company's unique approach lies in unraveling the causal relationships between cells’ intracellular activities and their responses in the patients’ heterogeneous microenvironment, predicting how cell modulation alters its behavior in patients. Synlico leverages a causal- and prediction-based approach to navigate the complexities and heterogeneity of diseases.

Synlico Inc. aims to enhance its impact on healthcare through cutting-edge research and development. The company is committed to making significant contributions to the field of biotechnology. We invite the manager of Synlico Inc. to create a customized and exclusive company showcase and product listing on our platform to further amplify their market presence.